Seizinger Bernd R. 4
4 · Aptose Biosciences Inc. · Filed Sep 16, 2022
Insider Transaction Report
Form 4
Seizinger Bernd R.
Director
Transactions
- Award
Stock Option (right to buy)
2022-09-14+50,000→ 50,000 totalExercise: $0.74Exp: 2032-09-14→ Common Shares (50,000 underlying)
Footnotes (1)
- [F1]Fifty percent (50%) of the options vest on September 14, 2023, twenty-five percent (25%) on September 14, 2024, and twenty-five percent (25%) on September 14, 2025.